Form 4 for PALI PALISADE BIO, INC.
Accepted 2023-09-14 00:00:00 ET · period of report 2023-09-13 · accession 0001493152-23-032655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-14 | 2023-09-13 | PALI | Finley John David | CEO, CFO, Dir | P - Purchase | $0.66 | +15.0K | 28.4K | +112% | +$9,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2023-09-13 | P | A | 15,000 | $0.66 | 28,394 | D | — | — | (F1) Reporting Person purchased 15,000 shares of Common Stock at prices ranging from $0.636 to $0.658 with a weighted average price per share of $0.655 on September 13, 2023. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer. |